Surufatinib Clinical Trials
7 recruitingDrug
Phase 26Phase 11Phase 41
Showing 1–7 of 7 trials
Recruiting
Phase 2
Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors
Pulmonary Neuroendocrine Tumor
Shanghai Chest Hospital96 enrolled4 locationsNCT07357623
Recruiting
Phase 4
Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms
Neuroendocrine TumorsNeuroendocrine Neoplasms
Shanghai Zhongshan Hospital350 enrolled4 locationsNCT07272512
Recruiting
Phase 2
Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma
MetastaticAppendix CarcinomaAdenocarcinoma of Small Intestine
Sun Yat-sen University36 enrolled1 locationNCT05472948
Recruiting
Phase 2
Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer
Non-small Cell Lung CancerTislelizumabConcurrent Chemoradiotherapy+2 more
Sun Yat-sen University80 enrolled1 locationNCT07086456
Recruiting
Phase 2
Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
Neuroendocrine Neoplasm
Peking University30 enrolled2 locationsNCT05165407
Recruiting
Phase 2
Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer
Advanced Biliary Tract Cancer
Dai, Guanghai35 enrolled1 locationNCT06708858
Recruiting
Phase 1Phase 2
The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
High-Risk Localized Soft Tissue Sarcoma
Fudan University52 enrolled1 locationNCT05839275